Resmed Inc Share Price and Company Fundamentals
Last traded: Today at 2:15 AM
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Key Metrics
PE ratio
24.53
PB ratio
0.57
Dividend yield
0.96%
Beta
0.88
Market cap
$52.17B
Enterprise value
$4.72B
Company profile
| Industry / Sector | Medical Instruments & Supplies / Healthcare |
|---|---|
| Website | https://www.resmed.com |
| Mailing address | 9001 Spectrum Center Boulevard San Diego CA 92123 United States |
| Phone / Fax | 858-836-5000 / |
Dividends
More: Resmed Inc Dividend history, yield and payout ratio
Dividend yield
0.96%
Dividend amount
$0.35
Payout ratio
22.35%
5Y Avg. yield
-%
Resmed Inc paid $0.35 dividend and the ex-dividend date was 11 Feb 2026.The dividend payout ratio is 22.35%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.RMD dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Feb 2026, following are the company executives and directors listed on Resmed Inc.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Michael J. Farrell BE, MBA, SM | CEO & Chairman | 53 | |
| Dr. Peter C. Farrell A.M., B.E., BE (Hons), Ph.D., ScD | Founder, Chair Emeritus & Non-Executive Director | 83 | |
| Mr. Brett A. Sandercock | Chief Financial Officer | 58 | |
| Mr. Michael J. Rider | Chief Legal Officer & Secretary | 67 | |
| Mr. Justin Leong | Chief Product Officer | 48 | |
| Mr. Alastair Robertson | Chief Information Officer | ||
| Ms. Sallilyn Schwartz | Chief Investor Relations Officer | ||
| Mr. Jim Ellis | Chief Compliance Officer | ||
| Ms. Yvonne-Katrin Pucknat | Chief Marketing Officer | 49 | |
| Ms. Vered Keisar | Chief People Officer |
Profitability and management effectiveness
Profit margin
27.53%
Operating margin
35.16%
Return on assets
14.74%
Return on equity
25.68%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Resmed Inc is 52.17B and its enterprise value is 4.72B. The enterprise value to revenue ratio of RMD is 0.87. The enterprise value to EBITDA ratio of RMD is 2.33.
The RMD's stocks Beta value is 0.88 making it 12% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Resmed Inc (RMD)
- Ansell (ANN)
- Cochlear (COH)
- Estia Health (EHE)
- Fisher & Paykel Healthcare Corporation (FPH)
- Healius (HLS)
- Nanosonics (NAN)
- Pro Medicus (PME)
- Polynovo (PNV)
- Ramsay Health Care (RHC)
- Sonic Healthcare (SHL)
Resmed Inc (ASX:RMD) Frequently Asked Questions
1. What is Resmed Inc's Stock Symbol?
Resmed Inc trades on ASX under the ticker symbol "RMD".
2. What is Resmed Inc's stock price today?
One share of RMD stock can currently be purchased for approximately $35.81.
3. How can I contact Resmed Inc?
Resmed Inc's mailing address is 9001 Spectrum Center Boulevard San Diego CA 92123 United States. The company can be reached via phone at 858-836-5000.
4. What is Resmed Inc's official website?
The official website of Resmed Inc is https://www.resmed.com.